Healthcare -
Biotechnology - NASDAQ - US
$ 1.39
-2.11 %
$ 161 M
Market Cap
-15.44
P/E
CHRS - COST OF REVENUE
Cost of Revenue CHRS - Coherus BioSciences, Inc.
163 M
LAST VALUE
68.12%
2 YEAR CAGR
118.95%
5 YEAR CAGR
17.93%
10 YEAR CAGR